LSE:TRX (Tissue Regenix Group plc)

About TRX

Tissue Regenix is a medical devices company. Its decellularisation technology removes DNA and other cellular material from animal and human tissue, which can then be used to repair diseased or worn-out body parts.
  • Tissue Regenix Group plc (LSE: TRX) Latest News

    Investing Articles

    2 cheap growth stocks I’d buy for the long term

    These two shares could offer a mix of growth and value in current market conditions.

    Read more »

    Investing Articles

    Why I’m not buying shares in Sirius Minerals plc just yet

    Edward Sheldon explains why he isn't buying into the Sirius Minerals plc (LON: SXX) story just yet.

    Read more »

    Investing Articles

    3 stocks you can buy today for up to 70% less than Neil Woodford paid!

    Should you snap up these Neil Woodford favourites at big discounts?

    Read more »

    Investing Articles

    Is this stock a buy after reporting a 150% increase in revenue?

    Should you add this fast-growing stock to your portfolio or is a lower-risk established giant a better bet?

    Read more »

    Investing Articles

    Are GlaxoSmithKline plc, Tissue Regenix Group plc and Optibiotix Health plc must-have health stocks?

    Are GlaxoSmithKline plc (LON:GSK), Tissue Regenix Group plc (LON:TRX) and Optibiotix Health plc (LON:OPTI) great picks for your portfolio?

    Read more »

    Investing Articles

    Why AstraZeneca plc, Dechra Pharmaceuticals plc And Tissue Regenix Group PLC Are A Perfect Healthcare Combination

    AstraZeneca plc (LON:AZN), Dechra Pharmaceuticals plc (LON:DPH) and Tissue Regenix Group PLC (LON:TRX) are a terrific trio to buy today.

    Read more »

    Investing Articles

    Why Neil Woodford Is Backing Technology

    Neil Woodford will be shopping for companies like Tissue Regenix Group PLC (LON:TRX), Imperial Innovations Group plc (LON:IVO) and IP…

    Read more »